Canadian industry joins forces to oppose user fees
This article was originally published in Clinica
The Canadian government's policy of recovering the cost of its services from industry is out of control and has no consistent approach or oversight, says a coalition of Canadian industry sectors. A thorough review of the cost-recovery programme should be conducted before any new charges are introduced, argues the coalition, which includes the medical device industry association, MEDEC.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.